Cancer Genetics and Epigenetics 2024, Vol.12, No.5, 254-269 http://medscipublisher.com/index.php/cge 267 Ju S.W., Chen C., Zhang J.H., Xu L., Zhang X., Li Z.Q., Chen Y.X., Zhou J.C., Ji F.Y., and Wang L.B., 2022, Detection of circulating tumor cells: opportunities and challenges, Biomarker Research, 10(1): 58. https://doi.org/10.1186/s40364-022-00403-2 PMID: 35962400 PMCID: PMC9375360 Kahounová Z., Pícková M., Drápela S., Bouchal J., Szczyrbová E., Navrátil J., and Souček K., 2023, Circulating tumor cell-derived preclinical models: current status and future perspectives, Cell Death and Disease, 14(8): 530. https://doi.org/10.1038/s41419-023-06059-6 PMID: 37591867 PMCID: PMC10435501 Kantara C., O'Connell, M.R., Luthra G., Gajjar A., Sarkar S., Ullrich R.L., and Singh P., 2014, Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis, Laboratory Investigation, 95(1): 100-112. https://doi.org/10.1038/labinvest.2014.133 PMID: 25347154 PMCID: PMC4281282 Krebs M.G,, Metcalf R.L., Carter L., Brady G., Blackhall F.H., and Dive C., 2014, Molecular analysis of circulating tumour cells-biology and biomarkers, Nature Reviews Clinical Oncology, 11(3): 129-144. https://doi.org/10.1038/nrclinonc.2013.253 PMID: 24445517 Labianca R., Beretta G.D., Kildani B., Milesi L., Merlin F., Mosconi S., Pessi M.A., Prochilo T., Quadri A., Gatta G., de Braud F., and Wils J., 2010, Colon cancer, Critical Reviews in Oncology/Hematology, 74(2): 106-133. https://doi.org/10.1016/j.critrevonc.2010.01.010 PMID: 20138539 Li C., He W., Wang N., Xi Z.P., Deng R.R., Liu X.Y., Kang R., Xie L., and Liu X., 2022, Application of microfluidics in detection of circulating tumor cells, Frontiers in Bioengineering and Biotechnology, 10: 907232. https://doi.org/10.3389/fbioe.2022.907232 PMID: 35646880 PMCID: PMC9133555 Li C.L., Li R., Wu X.Y., Zuo Y.F., Xiong G.X., Huang M., Sun Y.Q., Liao R., Xiao Y., Hu L.L., Gao C., and Yu YY.., 2022, Capture of heterogeneous circulating tumor cells in colorectal cancer patients on an immunomagnetic and anti-nonspecific adsorption platform, Analytical Chemistry, 94(44):15240-15249. https://doi.org/10.1021/acs.analchem.2c02416 PMID: 36279553 Lin D.F., Shen L.S., Luo M., Zhang K., Li J.F., Yang Q., Zhu F.F., Zhou D., Zheng S., Chen Y.D., and Zhou J.J., 2021, Circulating tumor cells: biology and clinical significance, Signal Transduction and Targeted Therapy, 6(1): 404. https://doi.org/10.1038/s41392-021-00817-8 PMID: 34803167 PMCID: PMC8606574 Liu J.L., Lian J.R., Chen Y.F., Zhao X., Du C.Z., Xu Y., Hu H.L., Rao H., and Hong X., 2021, Circulating tumor cells (CTCs): a unique model of cancer metastases and non-invasive biomarkers of therapeutic response, Frontiers in Genetics, 12: 734595. https://doi.org/10.3389/fgene.2021.734595 PMID: 34512735 PMCID: PMC8424190 Lu Y.J, Wang P., Peng J., Wang X., Zhu Y.W., and Shen N., 2017, Meta-analysis reveals the prognostic value of circulating tumour cells detected in the peripheral blood in patients with non-metastatic colorectal cancer, Scientific Reports, 7(1): 905. https://doi.org/10.1038/s41598-017-01066-y PMID: 28424486 PMCID: PMC5430457 Marcuello M., Vymetálková V., Neves R.P., Duran-Sanchon S., Vedeld H.M., Tham E., van Dalum G., Flügen G., García-Barberán V., Fijneman R.J., Castells A., Vodicka P., Lind G.E., Stoecklein N.H., Heitzer E., and Gironella M., 2019, Circulating biomarkers for early detection and clinical management of colorectal cancer, Molecular Aspects of Medicine, 69: 107-122. https://doi.org/10.1016/j.mam.2019.06.002 PMID: 31189073 Masuda T., Hayashi N., Iguchi T., Ito S., Eguchi H., and Mimori K., 2016, Clinical and biological significance of circulating tumor cells in cancer, Molecular Oncology, 10(3): 408-417. https://doi.org/10.1016/j.molonc.2016.01.010 PMID: 26899533 PMCID: PMC5528976 Memarpour S., Khalili-Tanha G., Ghannad A., Razavi M., Joudi M., Joodi M., Ferns G., Hassanian S., Khazaei M., and Avan A., 2021, The clinical application of circulating tumor cells and DNAs as prognostic and predictive biomarkers in gastrointestinal cancer, Current Cancer Drug Targets, 21(8): 676-688. https://doi.org/10.2174/1568009621666210311090531 PMID: 33719973 Myung J.H., Park S.J., Wang A.Z., and Hong S., 2017, Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs), Advanced Drug delivery Reviews, 125: 36-47. https://doi.org/10.1016/j.addr.2017.12.005 PMID: 29247765 PMCID: PMC6800256
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==